Intercontinental Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.52M | Sell |
18,724
-832
| -4% | -$67.3K | 0.36% | 53 |
|
|
2023
Q1 | $1.56M | Sell |
19,556
-4,036
| -17% | -$321K | 0.4% | 47 |
|
|
2022
Q4 | $1.6M | Sell |
23,592
-9,090
| -28% | -$615K | 0.47% | 34 |
|
|
2022
Q3 | $1.63M | Sell |
32,682
-696
| -2% | -$34.7K | 0.51% | 33 |
|
|
2022
Q2 | $1.86M | Sell |
33,378
-2,106
| -6% | -$117K | 0.5% | 31 |
|
|
2022
Q1 | $1.97M | Sell |
35,484
-1,242
| -3% | -$69K | 0.45% | 33 |
|
|
2021
Q4 | $2.06M | Sell |
36,726
-1,726
| -4% | -$96.7K | 0.43% | 34 |
|
|
2021
Q3 | $1.85M | Sell |
38,452
-10,066
| -21% | -$483K | 0.43% | 34 |
|
|
2021
Q2 | $2.03M | Buy |
48,518
+3,404
| +8% | +$143K | 0.4% | 33 |
|
|
2021
Q1 | $1.52M | Buy |
45,114
+4,978
| +12% | +$168K | 0.33% | 50 |
|
|
2020
Q4 | $1.4M | Buy |
40,136
+15,976
| +66% | +$558K | 0.34% | 53 |
|
|
2020
Q3 | $839K | Buy |
24,160
+15,022
| +164% | +$522K | 0.25% | 82 |
|
|
2020
Q2 | $299K | Buy |
9,138
+138
| +2% | +$4.52K | 0.1% | 147 |
|
|
2020
Q1 | $271K | Sell |
9,000
-404
| -4% | -$12.2K | 0.14% | 121 |
|
|
2019
Q4 | $303K | Buy |
9,404
+404
| +4% | +$13K | 0.25% | 70 |
|
|
2019
Q3 | $233K | Buy |
+9,000
| New | +$233K | 0.14% | 119 |
|